ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » New York » Rheumatology

Top Rheumatology Prescribers in New York

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
EDDYS DISLA M.D.

Rheumatology

20,184

$1.62M

605
506 are 65+

5%
patients receiving schedule two controlled substances

Avg: 3%

4%
patients receiving schedule three controlled substances

Avg: 5%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

34%
prescriptions for brand name drugs

Avg: 29%

$80
Average prescription price

Avg: $161

SHARON REVAN M.D.

Rheumatology

12,191

$629K

366
309 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 5%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 29%

$52
Average prescription price

Avg: $161

STANLEY MICHALSKI M.D.

Rheumatology

10,954

$1.1M

446
378 are 65+

16%
patients receiving schedule two controlled substances

Avg: 3%

29%
patients receiving schedule three controlled substances

Avg: 5%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 29%

$100
Average prescription price

Avg: $161

JIHAD ABIALMOUNA M.D.

Rheumatology

8,723

$734K

589
490 are 65+

2%
patients receiving schedule two controlled substances

Avg: 3%

12%
patients receiving schedule three controlled substances

Avg: 5%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

30%
prescriptions for brand name drugs

Avg: 29%

$84
Average prescription price

Avg: $161

BASIT QAYYUM M.D

Rheumatology

8,104

$456K

471
444 are 65+

2%
patients receiving schedule two controlled substances

Avg: 3%

5%
patients receiving schedule three controlled substances

Avg: 5%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

31%
prescriptions for brand name drugs

Avg: 29%

$56
Average prescription price

Avg: $161

ALAN GOLDMAN M.D.

Rheumatology

7,983

$855K

466
388 are 65+

6%
patients receiving schedule two controlled substances

Avg: 3%

4%
patients receiving schedule three controlled substances

Avg: 5%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

37%
prescriptions for brand name drugs

Avg: 29%

$107
Average prescription price

Avg: $161

CARLOS MARTINEZ M.D.

Rheumatology

7,575

$699K

585
464 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

6%
patients receiving schedule three controlled substances

Avg: 5%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 29%

$92
Average prescription price

Avg: $161

JITENDRA PATEL MD

Rheumatology

7,541

$593K

461
383 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 5%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 29%

$79
Average prescription price

Avg: $161

STELIOS VIENNAS MD

Rheumatology

7,458

$759K

542
479 are 65+

3%
patients receiving schedule two controlled substances

Avg: 3%

3%
patients receiving schedule three controlled substances

Avg: 5%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

34%
prescriptions for brand name drugs

Avg: 29%

$102
Average prescription price

Avg: $161

DIMITRIOS ASTERS MD

Rheumatology

7,383

$698K

499
436 are 65+

4%
patients receiving schedule two controlled substances

Avg: 3%

6%
patients receiving schedule three controlled substances

Avg: 5%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

33%
prescriptions for brand name drugs

Avg: 29%

$95
Average prescription price

Avg: $161

YELENA SOKOLOVA MD

Rheumatology

6,790

$826K

244
224 are 65+

6%
patients receiving schedule two controlled substances

Avg: 3%

9%
patients receiving schedule three controlled substances

Avg: 5%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

55%
prescriptions for brand name drugs

Avg: 29%

$122
Average prescription price

Avg: $161

SANDEEP GUPTA M.D.

Rheumatology

6,481

$588K

431
353 are 65+

6%
patients receiving schedule two controlled substances

Avg: 3%

4%
patients receiving schedule three controlled substances

Avg: 5%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 29%

$91
Average prescription price

Avg: $161

ROBERT FAFALAK MD

Rheumatology

6,425

$794K

490
345 are 65+

7%
patients receiving schedule two controlled substances

Avg: 3%

8%
patients receiving schedule three controlled substances

Avg: 5%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

33%
prescriptions for brand name drugs

Avg: 29%

$124
Average prescription price

Avg: $161

MARK GOLDSTEIN MD

Rheumatology

5,987

$1.55M

588
405 are 65+

18%
patients receiving schedule two controlled substances

Avg: 3%

11%
patients receiving schedule three controlled substances

Avg: 5%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

28%
prescriptions for brand name drugs

Avg: 29%

$259
Average prescription price

Avg: $161

GODDARD LAINJO MD

Rheumatology

5,875

$910K

461
341 are 65+

10%
patients receiving schedule two controlled substances

Avg: 3%

25%
patients receiving schedule three controlled substances

Avg: 5%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 29%

$155
Average prescription price

Avg: $161

JAMES FREEMAN MD

Rheumatology

5,430

$1.06M

404
281 are 65+

7%
patients receiving schedule two controlled substances

Avg: 3%

10%
patients receiving schedule three controlled substances

Avg: 5%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

26%
prescriptions for brand name drugs

Avg: 29%

$196
Average prescription price

Avg: $161

MARGARET LENCI MD

Rheumatology

5,176

$294K

406
361 are 65+

3%
patients receiving schedule two controlled substances

Avg: 3%

3%
patients receiving schedule three controlled substances

Avg: 5%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

20%
prescriptions for brand name drugs

Avg: 29%

$57
Average prescription price

Avg: $161

PEGGY ANN GARJIAN MD

Rheumatology

5,171

$1.27M

475
306 are 65+

6%
patients receiving schedule two controlled substances

Avg: 3%

13%
patients receiving schedule three controlled substances

Avg: 5%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

34%
prescriptions for brand name drugs

Avg: 29%

$245
Average prescription price

Avg: $161

YA JU CHANG MD

Rheumatology

5,165

$791K

540
416 are 65+

3%
patients receiving schedule two controlled substances

Avg: 3%

4%
patients receiving schedule three controlled substances

Avg: 5%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

35%
prescriptions for brand name drugs

Avg: 29%

$153
Average prescription price

Avg: $161

DONALD BERNSTEIN

Rheumatology

4,806

$242K

205
186 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 5%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 29%

$50
Average prescription price

Avg: $161

EDGARDO SALVADOR MD

Rheumatology

4,792

$917K

381
317 are 65+

6%
patients receiving schedule two controlled substances

Avg: 3%

28%
patients receiving schedule three controlled substances

Avg: 5%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

31%
prescriptions for brand name drugs

Avg: 29%

$191
Average prescription price

Avg: $161

AITEZAZ AHMED M.D.

Rheumatology

4,683

$1.4M

580
431 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 5%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

28%
prescriptions for brand name drugs

Avg: 29%

$299
Average prescription price

Avg: $161

DANILO SALDANA M.D.

Rheumatology

4,634

$286K

345
241 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

12%
patients receiving schedule three controlled substances

Avg: 5%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 29%

$62
Average prescription price

Avg: $161

VICTORIA KATZ MD

Rheumatology

4,581

$549K

334
256 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 5%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

31%
prescriptions for brand name drugs

Avg: 29%

$120
Average prescription price

Avg: $161

MARTIN MORELL MD

Rheumatology

4,525

$970K

507
300 are 65+

4%
patients receiving schedule two controlled substances

Avg: 3%

16%
patients receiving schedule three controlled substances

Avg: 5%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

28%
prescriptions for brand name drugs

Avg: 29%

$214
Average prescription price

Avg: $161

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank